Lupus causes a wide range of abnormal lab results because it can affect nearly every organ system. The most common screening test, the antinuclear antibody (ANA), is positive in roughly 98% of people with systemic lupus erythematosus (SLE). But ANA alone doesn’t confirm a diagnosis. Doctors typically look at a combination of blood counts, antibody panels, kidney function tests, inflammatory markers, and complement levels to diagnose and monitor the disease.
The ANA Screening Test
ANA is the entry point for lupus evaluation. A positive ANA at a titer of 1:80 or higher is essentially required before a lupus diagnosis is even considered under current classification criteria from the European and American rheumatology societies. The test picks up nearly all lupus cases, with a sensitivity around 98%, but it’s not specific to lupus. Many people with a positive ANA don’t have lupus at all. Other autoimmune conditions, infections, and even normal aging can produce a positive result, which is why additional testing is always needed.
Lupus-Specific Antibodies
Two antibody tests are highly specific to lupus: anti-double-stranded DNA (anti-dsDNA) and anti-Smith (anti-Sm). Both have a specificity of about 99%, meaning a positive result almost certainly points to lupus rather than another condition. The tradeoff is that they aren’t very sensitive. Anti-dsDNA is positive in only about 30% of lupus patients, and anti-Sm in roughly 26%. So a negative result on either test doesn’t rule lupus out.
Anti-dsDNA levels tend to rise and fall with disease activity, making them useful for tracking flares over time. Anti-Sm levels are more stable and serve mainly as a diagnostic marker.
Blood Count Abnormalities
A complete blood count (CBC) is one of the most revealing tests in lupus because the immune system frequently attacks blood cells directly. Low white blood cell counts (leukopenia) show up in about 40% of patients, and the most common subtype affected is lymphocytes, with low lymphocyte counts occurring in over 55% of cases. Anemia affects roughly 58% of lupus patients, often from chronic inflammation or, less commonly, from the immune system destroying red blood cells. Low platelet counts (thrombocytopenia) appear in about 33% of patients.
These blood count changes can be mild and go unnoticed, or they can be severe enough to cause fatigue, easy bruising, or increased infection risk. Doctors use the CBC both for initial diagnosis and for ongoing monitoring, since worsening counts can signal a flare.
Complement Levels: C3 and C4
Complement proteins are part of the immune system, and lupus consumes them. C3 and C4 are the two most commonly measured. Normal C3 ranges from 90 to 180 mg/dL, and normal C4 from about 12 to 50 mg/dL. During active lupus, the immune system chews through these proteins as it forms immune complexes, so their levels drop. As the disease improves with treatment, C3 and C4 climb back up.
Low complement is one of the weighted criteria used in the current lupus classification system, and tracking these levels over time gives doctors a useful signal of how active the disease is at any given moment.
ESR and CRP: A Distinctive Pattern
Lupus creates an unusual split between two common inflammation markers. The erythrocyte sedimentation rate (ESR) tends to rise sharply during a flare, averaging around 51 mm/hr, while C-reactive protein (CRP) stays relatively low, averaging about 5.4 mg/dL. This pattern of high ESR with a blunted CRP response is somewhat characteristic of lupus flares.
This distinction becomes clinically important when someone with lupus develops a fever. If CRP shoots up dramatically (averaging 11.2 mg/dL in one study), that points more toward an infection than a lupus flare. Researchers have found that an ESR-to-CRP ratio greater than 15 correctly identified a lupus flare as the cause of fever in 94% of cases, while a ratio below 2 pointed to infection.
Kidney Function Tests
Lupus nephritis, or kidney inflammation from lupus, is one of the most serious complications, and urine tests are the primary way to catch it early. The key marker is proteinuria, meaning protein spilling into the urine. A urine protein-to-creatinine ratio of 0.5 g/g or higher is the threshold at which current guidelines recommend a kidney biopsy to assess damage. Even lower levels (0.2 to 0.5 g/g) are considered a warning sign worth monitoring closely.
Doctors also look for blood in the urine, specifically more than five red blood cells per high-powered field on microscopy, and for cellular casts, which are clumps of cells that form in the kidney tubules. About 45% of patients whose kidney disease progresses show hematuria. Routine blood tests measuring creatinine and estimated kidney filtration rate round out the picture.
Antiphospholipid Antibodies
A significant number of lupus patients produce antibodies that increase the risk of blood clots. The three main antiphospholipid antibodies tested are lupus anticoagulant (LA), anticardiolipin antibodies, and anti-beta-2-glycoprotein-I antibodies. Despite its name, lupus anticoagulant actually promotes clotting rather than preventing it.
These antibodies carry real clinical consequences. Patients with lupus anticoagulant face roughly six times the normal risk of venous blood clots, while those with anticardiolipin antibodies have about double the risk. Lupus anticoagulant is also linked to kidney damage, with roughly four to five times higher odds of both acute and chronic renal lesions compared to lupus patients without these antibodies. Antiphospholipid antibodies are also a leading cause of pregnancy complications in lupus, including recurrent miscarriage.
Liver Tests
Liver enzyme abnormalities are less well known in lupus but not uncommon. About 21% of lupus patients show some form of liver abnormality. The most frequent finding is low albumin (a protein made by the liver), present in 42% of patients, and elevated globulin levels, seen in 43%. These shifts reflect chronic inflammation rather than direct liver damage in most cases.
Actual liver enzyme elevations are less common. About 7% of patients have elevated AST or ALT at more than twice the normal upper limit. In roughly 5% of patients, no other explanation for the elevated enzymes can be found, and the abnormality is attributed directly to lupus itself. Medications used to treat lupus can also raise liver enzymes, so distinguishing the cause matters for treatment decisions.
How These Labs Work Together
No single lab result confirms lupus. The current classification system uses a point-based approach: a positive ANA gets you in the door, and then findings across seven clinical categories and three immunological categories are weighted and scored. You need at least 10 points out of a possible 51 to meet the classification threshold. Hematologic abnormalities, low complement, and lupus-specific antibodies all carry significant point values.
In practice, a typical lupus workup might show a positive ANA, low complement, one or more low blood cell lines, elevated ESR with relatively normal CRP, and possibly proteinuria or antiphospholipid antibodies. The specific combination varies widely from person to person, which is part of what makes lupus notoriously difficult to diagnose. Repeating these labs over time is just as important as the initial results, since trends reveal disease activity more reliably than any single snapshot.